Dala Group LLC Takes $1.10 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Dala Group LLC acquired 4,048 UnitedHealth shares worth approximately $1.10 million during the first quarter, making UNH about 0.9% of its portfolio. Institutional investors collectively own 87.86% of the company.
• UnitedHealth reported quarterly earnings of $6.38 per share, beating expectations of $4.94, while revenue reached $112.03 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $455.92.
• The company increased its quarterly dividend to $2.32 per share, or $9.28 annually, representing a 2.2% yield. Despite positive turnaround expectations, UnitedHealth faces risks from medical costs, regulation, surprise-billing disputes, and Medicare Advantage changes.

Dala Group LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,048 shares of the healthcare conglomerate's stock, valued at approximately $1,098,000. UnitedHealth Group comprises approximately 0.9% of Dala Group LLC's investment portfolio, making the stock its 24th biggest position.

Several other institutional investors have also added to or reduced their stakes in the business. Founders Capital Management LLC grew its holdings in UnitedHealth Group by 3.0% during the fourth quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate's stock valued at $324,000 after purchasing an additional 29 shares during the period. Kellett Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 1.7% in the fourth quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate's stock worth $576,000 after buying an additional 29 shares in the last quarter. Successful Portfolios LLC grew its holdings in UnitedHealth Group by 2.6% during the 4th quarter. Successful Portfolios LLC now owns 1,194 shares of the healthcare conglomerate's stock valued at $411,000 after buying an additional 30 shares in the last quarter. Bell Investment Advisors Inc raised its position in shares of UnitedHealth Group by 14.4% during the 1st quarter. Bell Investment Advisors Inc now owns 246 shares of the healthcare conglomerate's stock valued at $67,000 after buying an additional 31 shares in the last quarter. Finally, Essential Partners LLC increased its position in shares of UnitedHealth Group by 7.7% during the 1st quarter. Essential Partners LLC now owns 433 shares of the healthcare conglomerate's stock valued at $117,000 after purchasing an additional 31 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 1.6%

NYSE UNH opened at $414.82 on Friday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. The company has a market capitalization of $376.72 billion, a PE ratio of 26.69, a P/E/G ratio of 1.44 and a beta of 0.62. The company has a fifty day moving average of $411.39 and a 200 day moving average of $348.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group's quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the business earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were paid a $2.32 dividend. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.21. UnitedHealth Group's dividend payout ratio (DPR) is presently 59.72%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on UNH shares. UBS Group lifted their price target on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a "buy" rating in a research note on Friday, July 17th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Mizuho boosted their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the company an "outperform" rating in a research report on Monday, July 20th. Argus upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price objective for the company in a report on Wednesday, April 22nd. Finally, Leerink Partners lifted their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an "outperform" rating in a report on Wednesday, June 17th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $455.92.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts at Zacks Research raised EPS forecasts for several future periods, including Q3 2026, Q1 2027, Q3 2027, Q4 2027, and Q1 2028. Zacks maintained a “Strong Buy” rating, reinforcing expectations for an earnings recovery.
• Positive Sentiment: Erste Group Bank increased its FY2026 EPS estimate to $19.85 from $18.33 and its FY2027 estimate to $22.44 from $20.87, maintaining a “Buy” rating. MarketBeat UnitedHealth analyst estimates
• Positive Sentiment: Recent coverage highlights UNH’s second-quarter earnings beat, lower medical-cost ratio, improved margins, and raised 2026 guidance as evidence that the company’s turnaround is gaining traction. Its diversified Optum platform and growing use of artificial intelligence are also viewed as longer-term strengths. UnitedHealth turnaround signal
• Positive Sentiment: A separate valuation update lifted the estimated fair value from $424.23 to $475.23, reflecting improved Medicare Advantage and Optum Health assumptions. The average brokerage recommendation remains equivalent to “Buy,” although the usefulness of broadly positive analyst ratings is questioned. UnitedHealth fair value update
• Neutral Sentiment: Commentary says the recent stock advance reflects a Medicare Advantage repricing strategy that management outlined months earlier, suggesting the market is reassessing earnings power rather than responding to a new operational announcement. UnitedHealth Medicare Advantage repricing analysis
• Negative Sentiment: Zacks reduced its Q4 2026 EPS estimate to $2.25 from $2.47 and trimmed its Q2 2028 forecast to $5.84 from $5.92. These isolated cuts may be contributing to caution even as the firm remains bullish overall.
• Negative Sentiment: UnitedHealth faces scrutiny over surprise-billing dispute costs, while broader risks include commercial-market trends, Medicaid exposure, and regulation. Medicare Advantage insurers are also redesigning 2027 plans, potentially affecting enrollment, benefits, and member retention. Cigna and UnitedHealth cost coverage

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.